PUBLICATION

Drugs & Medical Devices

Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.


PUBLICATION ARCHIVES

SEARCH THE ARCHIVES

Issue #84, December 2008

Prempro MDL Court Certifies, Forwards Statute of Limitations Question

The judge overseeing the Prempro MDL has certified a question to the Minnesotha Supreme Court, asking it to determine whether


Court Affirms Dismissal of Lipitor Complaints Based on Immunity Statute

A group of Lipitor plaintiffs who claimed they developed neurological and psychological injuries after taking the drug failed to plead


Issue #83, November 2008

Jury Awards $12.9 Million to Three Accutane Plaintiffs

A New Jersey jury has awarded nearly $13 million to three Florida residents who claim they developed inflammatory bowel disease


Paxil Wrongful Death Case Dismissed on Statute of Limitations Grounds

A judge who recently held that a Paxil failure-to-warn claim is not preempted by federal law has dismissed the case outright


Judge Denies GSK Motion to Reconsider Summary Judgment Order, Allows Appeal

Despite opining that GlaxoSmithKline still has not proven there exists an actual conflict between federal and state law, a federal court


Court: Failure-to-Warn Claims Against Generic Drug Manufacturers Preempted

A federal court has dismissed state law failure-to-warn claims in three cases brought against generic drug manufacturers


Judge Says Depo-Provera Injury Isn't Compensable, Upholds Judgment

A Depo-Provera plaintiff who blamed her attorney for failing to submit a timely motion to reconsider summary judgment would not


Gadolinium Plaintiff Can Sue Manufacturers, Health Care Facility

A non-diverse health care provider was not fraudulently joined to a complaint for injuries allegedly cause by a gadolinium contrast dye


Federal Judge Refuses to Extend Duty to Brand Name Reglan Manufacturer

A judge has ruled that state law does not permit an individual allegedly injured by a generic drug to pursue negligent misrepresentation


Judge Says FDA Permits Change in Generic Labels, Refuses Preemption Bid

Generic drug manufacturers can strengthen their warning labels without violating FDA rules, which prevent such changes only during


Past Issues:


VERDICTRACK

The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.

  • DEFENDANT
  • DISEASE / INJURY
  • PRODUCT
  • PUBLICATION
  • STATE
  • SEARCH BY EXPERT